LDR Holding Corp  

(Public, NASDAQ:LDRH)   Watch this stock  
Find more results for Stefan K. Widensohler
-1.05 (-3.04%)
Jan 30 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 33.40 - 34.84
52 week 21.70 - 40.38
Open 34.34
Vol / Avg. 103,817.00/226,835.00
Mkt cap 885.52M
P/E     -
Div/yield     -
EPS -1.00
Shares 26.06M
Beta     -
Inst. own 80%
Dec 2, 2014
LDR Holding Corp at Piper Jaffray Healthcare Conference
Nov 24, 2014
LDR Holding Corp at Brean Capital's Life Sciences Summit Conference
Nov 11, 2014
LDR Holding Corp at Stephens Fall Investment Conference
Nov 5, 2014
Q3 2014 LDR Holding Corp Earnings Call
Nov 5, 2014
Q3 2014 LDR Holding Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -5.62% -25.03%
Operating margin -6.24% -2.08%
EBITD margin - 1.52%
Return on average assets -4.97% -26.66%
Return on average equity -7.36% -118.87%
Employees 323 -
CDP Score - -


Suite 200, 13785 Research Boulevard
AUSTIN, TX 78750-1873
United States - Map
+1-512-3443333 (Phone)
+1-512-3443350 (Fax)

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


LDR Holding Corporation is a global medical device company focused on designing and commercializing novel and surgical technologies for the treatment of patients suffering from spine disorders. The Company�s primary products are based on its VerteBRIDGE fusion and Mobi non-fusion platforms, both of which are designed for applications in the cervical and lumbar spine. The Company�s VerteBRIDGE products are designed around its plating technology that enables surgeons to implant VerteBRIDGE devices with direct visualization of the disc and to affix the devices to the vertebrae from inside the spinal disc space. The Company�s Mobi non-fusion platform is highlighted by Mobi-C, a cervical disc replacement device with a patented mobile bearing core that is designed to replicate the natural anatomical movement of the spine by facilitating independent bending and twisting similar to a healthy disc.

Officers and directors

Christophe Lavigne Chairman of the Board, President, Chief Executive Officer
Age: 46
Bio & Compensation  - Reuters
Robert E. McNamara Chief Financial Officer, Executive Vice President
Age: 57
Bio & Compensation  - Reuters
Scott Way Executive Vice President, Compliance Officer, General Counsel, Secretary
Age: 42
Bio & Compensation  - Reuters
James Burrows Executive Vice President, Chief Operating Officer of LDR Spine
Age: 44
Bio & Compensation  - Reuters
Herve Dinville Executive Vice President - Research and Development of Medical
Age: 62
Bio & Compensation  - Reuters
Andre Potgieter Executive Vice President - U.S. Sales of LDR Spine
Age: 46
Bio & Compensation  - Reuters
Patrick Richard Executive Vice President - European Sales of Medical
Age: 50
Bio & Compensation  - Reuters
G. Joseph Ross Executive Vice President - Global Marketing of LDR Spine
Age: 46
Bio & Compensation  - Reuters
Joseph C. Aragona Director
Age: 56
Bio & Compensation  - Reuters
William W. Burke Independent Director
Age: 54
Bio & Compensation  - Reuters